Key facts
- This page summarizes Ivan Chen's Form 4 filing for PURE BIOSCIENCE, INC. (PURE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Jul 2022, 16:13.
Ivan Chen - 15 Jul 2022 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)
- Reporting relationship
- Director
- Issuer ticker
- PURE
- Reported as of
- 15 Jul 2022
- Net transaction value
- +$45,000
- SEC form
- 4
- Accepted by SEC
- 19 Jul 2022, 16:13:27 UTC
- Prior SEC filing
- 22 Jun 2021
- Next SEC filing
- 04 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ivan Chen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Chen filed Form 4 for PURE BIOSCIENCE, INC. (PURE) on 19 Jul 2022.
Change
- Previous filing in this sequence was filed on 22 Jun 2021.
- Current net transaction value: +$45,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PURE
transaction
Common Stock
Award
- Transaction value
- $45,000
- Shares
- +300,000
- Change %
- +67%
- Price
- $0.1500
- Shares after
- 750,000
- Date
- 15 Jul 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors.